Eric Wachter - Dec 2, 2024 Form 4 Insider Report for PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)

Role
CTO
Signature
/s/ Eric Wachter
Stock symbol
PVCT
Transactions as of
Dec 2, 2024
Transactions value $
$0
Form type
4
Date filed
12/4/2024, 09:43 PM
Previous filing
Jun 22, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PVCT Stock Options (Right to Buy) Award $0 +2.14M $0.00 2.14M Dec 2, 2024 Common Stock 2.14M $0.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest in three equal annual installments beginning on December 2, 2024.